ADCT
ADC Therapeutics SA
1.19
1 x 1.17
1 x 1.18
bid
ask
+
0.05
3.95%
11:24 AM
timesize
| Ytd | -66.43% | |
| 1y | -57.68% |
1.14
day range
1.19
0.78
52 week range
4.98
| Open | 1.14 | Prev Close | 1.14 | Low | 1.14 | High | 1.19 | Mkt Cap | 149.45M |
| Vol | 476.76K | Avg Vol | 1.84M | EPS | -0.97 | P/E | N/A | Forward P/E | -1.36 |
| Beta | 1.60 | Short Ratio | 6.98 | Inst. Own | 61.60% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-05 | 50-d Avg | 2.62 | 200-d Avg | 3.62 | 1yr Est | 8.40 |
| Income Statement | |||
| Total Revenue | 20.85M | ||
| Revenues (USD) | 20.85M | ||
| Cost of Revenue | 3.62M | ||
| Gross Profit | 17.24M | ||
| Operating Expenses | 42.48M | ||
| Research and Development Expense | 19.88M | ||
| Selling, General and Administrative Expense | 22.60M | ||
| Operating Income | -25.24M | ||
| Interest Expense | 12.35M | ||
| Net Income | -32.97M | ||
| Net Income Common Stock | -32.97M | ||
| Net Income Common Stock (USD) | -32.97M | ||
| Consolidated Income | -32.97M | ||
| Earnings per Basic Share | -0.21 | ||
| Earnings per Basic Share (USD) | -0.21 | ||
| Earnings per Diluted Share | -0.21 | ||
| Earning Before Interest & Taxes (EBIT) | -20.62M | ||
| Earning Before Interest & Taxes (USD) | -20.62M | ||
| Weighted Average Shares | 154.14M | ||
| Weighted Average Shares Diluted | 154.14M | ||
| Balance Sheet | |||
| Cash and Equivalents | 231.01M | ||
| Cash and Equivalents (USD) | 231.01M | ||
| Trade and Non-Trade Receivables | 31.05M | ||
| Current Assets | 276.77M | ||
| Property, Plant & Equipment Net | 1.20M | ||
| Total Assets | 291.50M | ||
| Debt Current | 4.64M | ||
| Total Debt | 116.67M | ||
| Current Liabilities | 67.63M | ||
| Debt Non-Current | 112.03M | ||
| Total Liabilities | 507.87M | ||
| Accumulated Retained Earnings (Deficit) | -1.67B | ||
| Accumulated Other Comprehensive Income | -802.00K | ||
| Shareholders Equity | -216.38M | ||
| Shareholders Equity (USD) | -216.38M | ||
| Assets Non-Current | 14.73M | ||
| Total Debt (USD) | 116.67M | ||
| Inventory | 17.06M | ||
| Liabilities Non-Current | 440.25M | ||
| Trade and Non-Trade Payables | 5.30M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 114.00K | ||
| Net Cash Flow from Financing | -583.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -30.32M | ||
| Capital Expenditure | -32.00K | ||
| Issuance (Purchase) of Equity Shares | 185.00K | ||
| Net Cash Flow from Investing | -32.00K | ||
| Net Cash Flow from Operations | -29.71M | ||
| Effect of Exchange Rate Changes on Cash | -5.00K | ||
| Share Based Compensation | 2.44M | ||